Positive EMA Scientific Advice Positions GeoVax for Expedited European Approval ATLANTA, GA - July 21, 2025 (NEWMEDIAWIRE) - ...

Sierra Leone faces a Clade II mpox outbreak, driving urgent health action and global calls for vaccine and response support.

NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage pioneer in host-mimetic nanomedicine, affirmed its preparedness to address the continued ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the ...

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the ...

Confirms Single Phase 3 Immuno-Bridging Trial Sufficient to Evaluate Efficacy and to Support a Marketing Authorization Application (MAA) For Vaccination against Mpox and Smallpox ATLANTA, GA - June 16 ...

The Director General of the World Health Organization, Tedros Ghebreyesus, has warned that mpox continues to pose a Public Health Emergency of International Concern (PHEIC), a formal declaration ...

Mathematical modelling work suggests that, since the PHEIC was determined in mid-August 2024 in the DRC, the transmission rate has decreased in certain health zones of the North Kivu and South ...

In July of 2022, mpox was declared a Public Health Emergency of International Concern, or PHEIC, by WHO during a surge in infections that led to more than 100,000 cases in 122 countries.

The WHO recently determined that a surge of mpox cases in several African countries constitutes a “public health emergency of international concern.” Here’s what this means for you.

With life-saving mpox vaccines barely trickling into Africa, cases continue to rise rapidly, including in Kinshasa, the capital of the DRC and home to 17 million people.